AM
PFE icon

Atwater Malick’s Pfizer PFE Stock Holding History

Atwater Malick’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-149,761
Closed -$4.16M – 81
2024
Q1 		$4.16M Sell
149,761
-24,178
-14% -$671K 1.46% 25
2023
Q4 		$5.01M Buy
173,939
+8,100
+5% +$245K 1.96% 23
2023
Q3 		$5.5M Buy
165,839
+1,964
+1% +$69.5K 2.42% 19
2023
Q2 		$6.01M Buy
163,875
+7,683
+5% +$299K 2.57% 18
2023
Q1 		$6.37M Buy
156,192
+4,407
+3% +$190K 2.99% 18
2022
Q4 		$7.78M Buy
151,785
+4,264
+3% +$204K 3.83% 13
2022
Q3 		$6.46M Buy
147,521
+2,979
+2% +$145K 3.61% 16
2022
Q2 		$7.58M Buy
144,542
+2,374
+2% +$121K 3.99% 8
2022
Q1 		$7.36M Buy
142,168
+4,734
+3% +$246K 3.55% 13
2021
Q4 		$8.12M Buy
137,434
+3,142
+2% +$156K 3.77% 9
2021
Q3 		$5.78M Buy
134,292
+3,800
+3% +$168K 3.05% 18
2021
Q2 		$5.11M Buy
130,492
+6,707
+5% +$261K 2.83% 21
2021
Q1 		$4.49M Sell
123,785
-3,185
-3% -$113K 2.75% 21
2020
Q4 		$4.67M Sell
126,970
-3,823
-3% -$140K 2.94% 19
2020
Q3 		$4.55M Buy
130,793
+2,047
+2% +$71.8K 3.19% 17
2020
Q2 		$3.99M Buy
128,746
+4,391
+4% +$149K 3.14% 19
2020
Q1 		$3.85M Buy
124,355
+1,657
+1% +$56.5K 3.7% 16
2019
Q4 		$4.56M Buy
122,698
+5,227
+4% +$186K 3.63% 16
2019
Q3 		$4M Buy
117,471
+7,563
+7% +$275K 3.36% 16
2019
Q2 		$4.52M Buy
109,908
+1,677
+2% +$66.6K 4.14% 10
2019
Q1 		$4.36M Buy
108,231
+426
+0.4% +$17.1K 4.27% 9
2018
Q4 		$4.46M Buy
+107,805
New +$4.48M 5% 2

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Atwater Malick's PFE Position: Q2 2024 in Review

Atwater Malick sold out of Pfizer (PFE) in Q2 2024, closing a stake of 149,761 shares — an estimated $4.16M sold.

Atwater Malick first reported a position in PFE in Q4 2018 and held it in 22 quarters. The position peaked at $8.12M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Atwater Malick reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Atwater Malick sold 149,761 Pfizer shares in Q2 2024, an estimated $4.16M.
  • Atwater Malick first reported a position in Pfizer in Q4 2018 and held it in 22 quarters.
  • Atwater Malick's Pfizer position peaked at $8.12M in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Atwater Malick's 13F filing for Q2 2024, filed 17 Jul 2024.